🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: Evaluate the percentage of patients achieving glycosyla...
Status
Completed
Location
Administrative office
Start Date
2011-05
Trial ID
NCT01202474
Treatments Being Tested
This is a pilot study to examine and compare the efficacy of supervised inj...
Status
Completed
Location
Yale University
Start Date
2017-10-01
Trial ID
NCT03400501
Treatments Being Tested
This study compares insulin 287 (a possible new medicine) to insulin glargi...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2019-05-09
Trial ID
NCT03922750
Treatments Being Tested
This was a four month dose ranging study followed by a 24 to 48 month exten...
Status
Terminated
Location
Anasazi Internal Medicine
Start Date
2009-04
Trial ID
NCT00900146
Treatments Being Tested
BEYOND represents an open-label, parallel, three-arm randomized controlled ...
Status
Completed
Location
Unit of Endocrinology and Metabolic Diseases
Start Date
2019-11-27
Trial ID
NCT04196231
Treatments Being Tested
The study will look at the efficacy and safety of NNC0268-0965 (referred to...
Status
Completed
Location
Profil GmbH & Co. KG
Start Date
2020-10-21
Trial ID
NCT04575181
Treatments Being Tested
The purpose of this study is: * To compare blood glucose (blood sugar) con...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2011-12
Trial ID
NCT01468987
Treatments Being Tested
Primary Objective: 6 To assess the efficacy of insulin glargine given once...
Status
Completed
Location
Investigational Site Number 156006
Start Date
2011-02
Trial ID
NCT01223131
Treatments Being Tested
The purpose of the study is to determine whether in patients with early typ...
Status
Completed
Location
University of Calgary
Start Date
2015-12
Trial ID
NCT02561130
Treatments Being Tested
This study was the extension of the LANTU\_C\_02761 study named EASIE and i...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2009-06
Trial ID
NCT00851903
Treatments Being Tested